$0.286000
-0.003-1.05%
At close: Jul 19, 4:44 PM EDT
$0.283000
-0.0030-1.05%
After Hours: Jul 19, 4:44 PM EDT
15 minutes delayed
Coeptis Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Coeptis Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
COEP | Coeptis Therapeutics | -$0.14 | — | — | — | $0.00 | — | — | — | 08/09/2024 | Get Alert |
COEP | Coeptis Therapeutics | -$0.39 | — | -$0.08 | — | $0.00 | — | $0.00 | — | 05/10/2024 | Get Alert |
COEP | Coeptis Therapeutics | -$3.02 | -$0.12 | -$0.08 | 33.33% | $0.00 | — | $0.00 | — | 03/26/2024 | Get Alert |
COEP | Coeptis Therapeutics | -$0.06 | — | -$0.23 | — | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
COEP | Coeptis Therapeutics | -$0.75 | -$0.20 | -$0.14 | 30.00% | $0.00 | — | $0.00 | — | 08/11/2023 | Get Alert |
COEP | Coeptis Therapeutics | — | -$0.20 | -$0.39 | -95.00% | — | — | $0.00 | — | 05/15/2023 | Get Alert |
COEP | Coeptis Therapeutics | — | — | -$3.02 | — | — | — | $0.00 | — | 03/29/2023 | Get Alert |
COEP | Coeptis Therapeutics | $0.45 | — | -$0.06 | — | $0.00 | — | $0.00 | — | 11/18/2022 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-26 | $-0.08 | $-0.12 | 33.3 % |
Jun 2023 | 2023-08-11 | $-0.14 | $-0.20 | 30.0 % |
Mar 2023 | 2023-05-15 | $-0.39 | $-0.20 | -95.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Coeptis Therapeutics (COEP) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 10, 2024 for Q1.
The Actual EPS was $-0.08, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.